Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Concordance analysis and diagnostic test accuracy review of IDH1 immunohistochemistry in glioblastoma.

Brain tumor pathology - 1 Oct 2016

Pyo Jung-Soo, Kim Nae Yu, Kim Roy Hyun Jai, Kang Guhyun

Abstract excerpt

The study investigated isocitrate dehydrogenase (IDH) 1 immunohistochemistry (IHC) positive rate and concordance rate between IDH1 IHC and molecular test in glioblastoma. The current study included 1360 glioblastoma cases from sixteen eligible studies. Meta-analysis, including subgroup analysis by antibody clones and cut-off values, for IDH1 IHC positive rate was conducted. In addition, we performed a concordance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Brain Neoplasms
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Glioblastoma

Share to Immunohistochemistry

Share to Isocitrate Dehydrogenase

Share to Mutation

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 27638721
DOI: 10.1007/s10014-016-0272-6

Genes

IDH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Concordance analysis and diagnostic test accuracy review of IDH1 immunohistochemistry in glioblastoma.PMID 27638721Read ↗

IDH1 mutation is associated with improved overall survival in patients with glioblastoma: a meta-analysis.Semantic proximity Read ↗

Assessment of the Association between Isocitrate Dehydrogenase 1 Mutation and Mortality Risk of Glioblastoma Patients.Semantic proximity Read ↗

IDH1/IDH2 mutations define the prognosis and molecular profiles of patients with gliomas: a meta-analysis.Semantic proximity Read ↗

IDH testing in diagnostic neuropathology: review and practical guideline article invited by the Euro-CNS research committee.Semantic proximity Read ↗

Genetics and Epigenetics of Glioblastoma: Applications and Overall Incidence of IDH1 MutationSemantic proximity Read ↗

Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas.Semantic proximity Read ↗

Determining IDH-Mutational Status in Gliomas Using IDH1-R132H Antibody and Polymerase Chain ReactionSemantic proximity Read ↗

[Isocitrate dehydrogenase type I mutation as a prognostic factor in glioblastoma and a literature review].Semantic proximity Read ↗

Development and external validation of a clinical prediction model for survival in patients with IDH wild-type glioblastomaSemantic proximity Read ↗

Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencingSemantic proximity Read ↗

The definition of primary and secondary glioblastoma.Semantic proximity Read ↗

Unraveling the tumor-promoting role of wildtype Isocitrate dehydrogenase 1 (IDH1) in human gliomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.